Correlation Between Vivani Medical and Opus Genetics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vivani Medical and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivani Medical and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivani Medical and Opus Genetics,, you can compare the effects of market volatilities on Vivani Medical and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivani Medical with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivani Medical and Opus Genetics,.

Diversification Opportunities for Vivani Medical and Opus Genetics,

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vivani and Opus is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Vivani Medical and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Vivani Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivani Medical are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Vivani Medical i.e., Vivani Medical and Opus Genetics, go up and down completely randomly.

Pair Corralation between Vivani Medical and Opus Genetics,

Given the investment horizon of 90 days Vivani Medical is expected to generate 0.63 times more return on investment than Opus Genetics,. However, Vivani Medical is 1.58 times less risky than Opus Genetics,. It trades about -0.03 of its potential returns per unit of risk. Opus Genetics, is currently generating about -0.05 per unit of risk. If you would invest  164.00  in Vivani Medical on August 28, 2024 and sell it today you would lose (27.00) from holding Vivani Medical or give up 16.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vivani Medical  vs.  Opus Genetics,

 Performance 
       Timeline  
Vivani Medical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vivani Medical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Vivani Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Vivani Medical and Opus Genetics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vivani Medical and Opus Genetics,

The main advantage of trading using opposite Vivani Medical and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivani Medical position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.
The idea behind Vivani Medical and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories